Head and Neck Cancer in the Elderly: A Retrospective Study over 10 Years (1999 - 2008)
© Kruse et al; licensee BioMed Central Ltd. 2010
Received: 2 August 2010
Accepted: 5 October 2010
Published: 5 October 2010
Treatment of elderly patients is in many ways different from that for younger ones. The aim of the present study was to identify the particular characteristics and needs of elderly patients suffering from head and neck cancer. From these patterns, considerations for this special group can be deduced.
Patients and Material
The subjects for this study consisted of 376 patients suffering from head and neck cancer that were treated between 1999 and 2008, 99 (26.3.%) of whom were older than 70 years and were evaluated retrospectively concerning smoking/alcohol abuse, ASA status, kind of malignant neoplasm, localization and treatment.
The male-female ratio was 53:46, and mean age, 79 years (71 - 98). Out of 95 patients with a squamous cell carcinoma, 4 patients had a verrucous form. Out of 99 patients, 26 had a maxillary carcinoma and 12 patients had experienced previous non-head-and-neck cancer. An ASA score of 2 or 3 was found in 86 of the patients.
The group of patients with head and neck cancer who were older than 70 years was characterized by a higher portion of female patients, a higher number of maxillary carcinomas, and a higher prevalence of previous second cancer.
Making decisions in cancer therapy for elderly patients is challenging. Patients suffering from operable head and neck cancer should be treated with curative intent and with regard to quality of life if a careful assessment of comorbidities is performed preoperatively.
The percentage of elderly people with head and neck cancer is rising due to an overall increase in life expectancy. Age has been shown to be an independent predictor of perioperative outcome, morbidity, and mortality risk. The main risk factors for head and neck cancer can be smoking and alcohol consumption, and these factors are also often associated with cardiovascular and pulmonary comorbidities, leading to a challenge concerning treatment decisions in this patient group.
- Increased chest wall rigidity
- Decreased functional alveolar surface area, decreased gas exchange
- Decreased respiratory muscle strength and endurance
- Decreased activity of hepatic cholinesterase
- Decrease in microsomal demethylation pathway
- Reduced glomerular filtration rate
- Decreased renal blood flow
- Reduction in total body water
- Reduced skeletal mass
- Reduced cortisol secretion
- Increased myocardial stiffness
- Increased aortic impedance
- Increased left atrium size
- Increased vascular stiffness
- Decreased β-adrenoceptor responsiveness
- Reduced total body water
- Reduced body mass
- Reduced serum albumin
- Reduced glomerular filtration rate
- Reduced renal blood flow
- Reduced concentrating ability
- Reduced hepatic blood flow
- Reduced activity of microsomal oxidizing system
In the literature, no exact age seems to be associated with the word "elderly." In any case, surgical indications should not be based on age, but rather on risk assessment. Socinski et al. defined an "old patient" as one whose health status has begun to interfere with oncological decision-making guidelines . Therefore, some authors recommend using the ASA score as a tool for risk assessment [2–4].
Postoperative delirium is a common complication, with the overall incidence estimated at 10% in elderly patients following major elective non-cardiac surgery . It usually presents around 24 hours postoperatively, resolving in most patients within 48 hours, but episodes can last for months . With delirium the course usually fluctuates and revolves over some days, up to a week, but with dementia symptoms are progressive. Hallucinations and delusions are also often absent in dementia, unlike in delirium. Concerning therapy, Dexmedetomidine is recommended for long-term sedation in the intensive care unit (ICU) as it leads to a decreased incidence of ICU delirium [9, 10], while low-dose Haloperidol or Donazepil does not reduce the incidence [11–13].
In general, preoperative risk assessment is predictive for the development of postoperative morbidity [14–16]. Serletti et al.  regarded surgical time longer than 10 hours as a predictive factor for development of postoperative surgical complications. Further factors are large fluid shifts and significant blood loss. Another important factor in reconstructive failure seems to be the presence of peripheral vascular disease.
Concerning chemotherapy, Shayne et al. reported that in patients ≥ 70 years who were receiving full-dose chemotherapy, increasing age alone did not increase the risk of hematologic toxicity .
The aim of the present study is to identify the concerns and needs of elderly patients suffering from head and neck cancer. From these patterns special considerations for this group can be deduced.
Patients and Material
Out of 376 patients treated from 1999 through 2008 that were suffering from head and neck cancer, 99 (26.3%) were older than 70 years. This group was evaluated retrospectively concerning smoking/alcohol abuse, ASA status, kind of malignant neoplasm, location of malignancy, treatment, and outcome.
Gender distribution, smoking, alcohol
Kind of malignant neoplasm, location
ASA status, general diseases
Muir et al. estimated that as many as 24% of head and neck cancers are found in patients older than 70 years , and this was supported by our study. A higher female proportion, as in the present study, was also confirmed by Sarini et al. .
Furthermore, in the present study the rate of patients with alcohol abuse or smoking risk factors was found to be lower than that in younger patient groups. This finding follows the logic that malignant tumors occur earlier under the influence of risk factors, but are also likely to occur without them as time passes by. Malignancy may interfere with accumulation of mutations, decreased efficiency in DNA repair, and reduced immune surveillance.
Concerning the higher portion of maxillary carcinomas in elderly patients, similar results can be shown in other studies [20, 21]. These findings are also important with regard to therapy planning because performing elective neck dissections for maxillary carcinoma is still controversial. It is also striking that, particularly in maxillary carcinoma, the proportion of females is higher than that of males .
Four patients had a verrucous form; this type of well-differentiated squamous cell carcinoma is well known in elderly patients .
In deciding which treatment strategy would be suitable for an individual elderly patient, a comprehensive geriatric assessment seems to be the essential step, because age by itself is an unreliable parameter for decision making. In the present study, only 3 patients had an ASA status of 1, and the predominant therapy was primary closure.
Due to changed renal function (reduced glomerular filtration rate, decreased renal blood flow) and changed hepatic metabolism (reduced hepatic blood flow and reduced activity of the microsomal oxidizing system), drug distribution is also changed in elderly patients. Moreover, increased myocardial stiffness, increased aortic impedance, increased left atrium size, and increased vascular stiffness, in addition to decreased β-adrenoceptor responsiveness, must be considered before a surgical treatment is planned for elderly patients (Table 1).
Though our population is becoming older and, therefore, the risk of developing cancer is also increasing, little research evaluating age-related toxicities has been conducted, and age-related guidelines for chemotherapy administration are often missing. The therapy decision should be based on the patient's wishes, ASA score, and combined quality of life and function, instead of being based on the patient's age and years of life expectancy.
In 810 patients older than 65 years who had undergone major head and neck resections under general anaesthesia, Morgan et al. reported a mortality rate as low as 3.5% . In addition, Jones et al. reported no significant differences in perioperative or postoperative complications between head and neck cancer patients older than 70 years and patients younger than 66 years, although the older group had a higher frequency of morbid preoperative conditions . In the present study the ASA score was applied preoperatively in order to evaluate the individual surgical risk, and none of the patients died perioperatively.
Controversy still surrounds microvascular free tissue transfer. Studies dealing with free tissue in the elderly have been done for those aged 50 years [3, 25], 60 years, 65 years[2, 15], and 70 years . The flap loss rate in these studies ranged from 1% out of 92 patients  to 16.7% out of 47 patients [14, 24].
Blackwell et al. reported that microvascular reconstructions in elderly patients are reliable, but the incidence of medical complications and costs has significantly increased . The success rate of free flaps seems no different from that for other age groups, but postoperative medical complications seem to be directly related to the presence of concurrent illness . In the current study a microvascular reconstruction was performed in only 13 patients; in all cases it was for mandible/mouth floor or tongue reconstruction. For maxilla, the most common closure was performed by an obturator prosthesis, followed by primary closure or temporal/nasolabial flaps.
Even if the concept of "elderly" has no clearly defined parameters, these patients do have a different pattern of head and neck tumors with regard to risk factors, tumor entities, and treatment options. The group of patients older than 70 years with head and neck cancer is characterized by a higher proportion of female patients, a higher number of maxillary carcinomas, and a higher prevalence of previous cancers.
Therefore the elderly patient does require an exact evaluation of his biological situation and an especially individual treatment concept.
Conflict of interests
The authors declare that they have no competing interests.
- Socinski MA, Morris DE, Masters GA, Lilenbaum R: Chemotherapeutic management of stage IV non-small cell lung cancer. Chest. 2003, 123: 226S-243S. 10.1378/chest.123.1_suppl.226S.View ArticlePubMedGoogle Scholar
- Serletti JM, Higgins JP, Moran S, Orlando GS: Factors affecting outcome in free-tissue transfer in the elderly. Plast Reconstr Surg. 2000, 106: 66-70. 10.1097/00006534-200007000-00012.View ArticlePubMedGoogle Scholar
- Ozkan O, Ozgentas HE, Islamoglu K, Boztug N, Bigat Z, Dikici MB: Experiences with microsurgical tissue transfers in elderly patients. Microsurgery. 2005, 25: 390-395. 10.1002/micr.20136.View ArticlePubMedGoogle Scholar
- Jones NF, Jarrahy R, Song JI, Kaufman MR, Markowitz B: Postoperative medical complications--not microsurgical complications--negatively influence the morbidity, mortality, and true costs after microsurgical reconstruction for head and neck cancer. Plast Reconstr Surg. 2007, 119: 2053-2060. 10.1097/01.prs.0000260591.82762.b5.View ArticlePubMedGoogle Scholar
- Priebe HJ: The aged cardiovascular risk patient. Br J Anaesth. 2000, 85: 763-778. 10.1093/bja/85.5.763.View ArticlePubMedGoogle Scholar
- Lakatta EG: Cardiovascular aging research: the next horizons. J Am Geriatr Soc. 1999, 47: 613-625.View ArticlePubMedGoogle Scholar
- Rasmussen LS, Moller JT: Central nervous system dysfunction after anesthesia in the geriatric patient. Anesthesiol Clin North America. 2000, 18: 59-70. 10.1016/S0889-8537(05)70149-8. viView ArticlePubMedGoogle Scholar
- Duppils GS, Wikblad K: Acute confusional states in patients undergoing hip surgery. a prospective observation study. Gerontology. 2000, 46: 36-43. 10.1159/000022131.View ArticlePubMedGoogle Scholar
- Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, Rocha MG: Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009, 301: 489-499. 10.1001/jama.2009.56.View ArticlePubMedGoogle Scholar
- Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, et al: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007, 298: 2644-2653. 10.1001/jama.298.22.2644.View ArticlePubMedGoogle Scholar
- Liptzin B, Laki A, Garb JL, Fingeroth R, Krushell R: Donepezil in the prevention and treatment of post-surgical delirium. Am J Geriatr Psychiatry. 2005, 13: 1100-1106.View ArticlePubMedGoogle Scholar
- Sampson EL, Raven PR, Ndhlovu PN, Vallance A, Garlick N, Watts J, Blanchard MR, Bruce A, Blizard R, Ritchie CW: A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. Int J Geriatr Psychiatry. 2007, 22: 343-349. 10.1002/gps.1679.View ArticlePubMedGoogle Scholar
- Kalisvaart KJ, de Jonghe JF, Bogaards MJ, Vreeswijk R, Egberts TC, Burger BJ, Eikelenboom P, van Gool WA: Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc. 2005, 53: 1658-1666. 10.1111/j.1532-5415.2005.53503.x.View ArticlePubMedGoogle Scholar
- Bonawitz SC, Schnarrs RH, Rosenthal AI, Rogers GK, Newton ED: Free-tissue transfer in elderly patients. Plast Reconstr Surg. 1991, 87: 1074-1079. 10.1097/00006534-199106000-00009.View ArticlePubMedGoogle Scholar
- Chick LR, Walton RL, Reus W, Colen L, Sasmor M: Free flaps in the elderly. Plast Reconstr Surg. 1992, 90: 87-94. 10.1097/00006534-199207000-00013.View ArticlePubMedGoogle Scholar
- Malata CM, Cooter RD, Batchelor AG, Simpson KH, Browning FS, Kay SP: Microvascular free-tissue transfers in elderly patients: the leeds experience. Plast Reconstr Surg. 1996, 98: 1234-1241. 10.1097/00006534-199612000-00018.View ArticlePubMedGoogle Scholar
- Shayne M, Culakova E, Wolff D, Poniewierski MS, Dale DC, Crawford J, Lyman GH: Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy. Cancer. 2009, 115: 5319-5328. 10.1002/cncr.24560.View ArticlePubMedGoogle Scholar
- Muir CS, Storm HH, Polednak A: Brain and other nervous system tumours. Cancer Surv. 1994, 19-20: 369-392.PubMedGoogle Scholar
- Sarini J, Fournier C, Lefebvre JL, Bonafos G, Van JT, Coche-Dequeant B: Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases. Arch Otolaryngol Head Neck Surg. 2001, 127: 1089-1092.View ArticlePubMedGoogle Scholar
- Montes DM, Schmidt BL: Oral maxillary squamous cell carcinoma: management of the clinically negative neck. J Oral Maxillofac Surg. 2008, 66: 762-766. 10.1016/j.joms.2007.12.017.View ArticlePubMedGoogle Scholar
- Kruse AL, Graetz KW: Cervical metastases of squamous cell carcinoma of the maxilla: a retrospective study of 9 years. Head Neck Oncol. 2009, 1 (1): 28-10.1186/1758-3284-1-28.PubMed CentralView ArticlePubMedGoogle Scholar
- Kruse AL, Graetz KW: Carcinoma cuniculatum: a rare entity in the oral cavity. J Craniofac Surg. 2009, 20: 1270-1272. 10.1097/SCS.0b013e3181ace06b.View ArticlePubMedGoogle Scholar
- Morgan RF, Hirata RM, Jaques DA, Hoopes JE: Head and neck surgery in the aged. Am J Surg. 1982, 144: 449-451. 10.1016/0002-9610(82)90420-2.View ArticlePubMedGoogle Scholar
- Jones AS, Beasley N, Houghton D, Husband DJ: The effects of age on survival and other parameters in squamous cell carcinoma of the oral cavity, pharynx and larynx. Clin Otolaryngol Allied Sci. 1998, 23: 51-56. 10.1046/j.1365-2273.1998.00086.x.View ArticlePubMedGoogle Scholar
- Shestak KC, Jones NF: Microsurgical free-tissue transfer in the elderly patient. Plast Reconstr Surg. 1991, 88: 259-263. 10.1097/00006534-199108000-00014.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.